Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery

Drug Delivery

Volumn 15, Issue 2, 2008, Pages 127-139

  Reis, Catarina Pinto ^a   Ribeiro, António J ^a   Veiga, Francisco ^a   Neufeld, Ronald J ^b   Damgé, Christiane ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Insulin; Nanospheres; Oral Delivery; Polyelectrolyte complexes

Indexed keywords

ALBUMIN; ALGINIC ACID; BIOMATERIAL; CHITOSAN; DEXTRAN; GLUCOSE; INSULIN; NANOPARTICLE; NANOSPHERE; POLYELECTROLYTE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; DIGESTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GLUCOSE BLOOD LEVEL; MALE; NANOPHARMACEUTICS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT;

ALBUMINS; ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROLYTES; EXCIPIENTS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NANOPARTICLES; PARTICLE SIZE; PEPSIN A; POLYMERS; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VISCOSITY;

EID: 39749142081     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540801905165     Document Type: Article

References (44)

1. Becherán-Marón, L., Peniche, C., and Argüelles-Monal, W. 2004. Study of the interpolyelectrolyte reaction between chitosan and alginate: Influence of alginate composition and chitosan molecular weight. Int. J. Biol. Macromol. 34:127-133.
2. Boonsongrit, Y., Mitrevej, A., and Mueller, B. W. 2006. Chitosan drug binding by ionic interaction. Eur. J. Pharm. Biopharm. 62:267-274.
3. Burting, P. 2003. Nutrional value of seaweeds. EJEAFChe 2:498-503.
4. Chen, Y., Mohanraj, V. J., and Parkin, J. E. 2003. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Let. Pept. Sci. 10:621-629.
5. Chien, Y.W. 1996. Human insulin: basic sciences to therapeutic uses. Drug Dev. Ind. Pharm. 22:753-789.
6. Coppi, G., Iannuccelli, V., Leo, E., Bernabei, M. T., and Cameroni, R. 2001. Chitosan-alginate microparticles as a protein carrier. Drug Dev. Ind. Pharm. 27:393-400.
7. Damgé, C., Maincent, P., and Ubrich, N. 2007. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control. Rel. 117:163-170.
8. Damgé, C., Michel, C., Aprahamian, M., and Couvreur, P. 1988. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246-251.
9. Donini, C., Robinson, D. N., Colombo, P., Giordano, F., and Peppas, N. A. 2002. Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int. J. Pharm. 245:83-91.
10. Draget, K. I., Skj̊ak-Braek, G., and SmidsrØd, O. 1994. Alginic acid gels: the effect of alginate chemical composition and molecular weight. Carbohydr. Polym. 25:31-38.
11. Gaserod, O., Smidsrod, O., and Skjak-Braek, G. 1998. Microcapsules of alginate-chitosan-I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 19:1815-25.
12. Gursoy, A., and Cevik, S. 2000. Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium. J. Microencapsul. 17:565-575.
13. Hari, P. R., Chandy, T., and Sharma, C.P. 1996. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13:319-29.
14. Hasegawa, M., K. Yagi, Iwakawa, S., and Hirai, M. 2001. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. J. Cancer Res. 92:459-466.
15. Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., and Alonso, M. J. 2001. Chitosan nanoparticles as delivery system for doxorubicin. J. Control. Rel. 73:255-267.
16. Jerry, N., Anitha, Y., Sharma, C. P., and Sony, P. 2001. In vivo absorption studies of insulin from an oral delivery system. Drug Deliv. 8:19-23.
17. Lee, D. W., Hwang, S. J., Park, J. B., and Park, H. J. 2003. Preparation and release characteristics of polymer-coated and blended alginate microspheres. J. Microencapsul. 20:179-92.
18. Lee, K. Y., Park, W. H., and Ha, W. S. 1997. Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. J. Appl. Polym. Sci. 63:425-432.
19. Lerco, M. M., Spadella, C. T., Machado, J. L. M., Schellini, S. A., and Pavodini, C. R. 2003. Caracterização de um modelo experimental dediabetes mellitus, induzido pela aloxana em ratos. Estudo clínico e laboratorial. Acta Cirúrg. Brasil 18:136-142.
20. Mesiha, M. S., Sidhom, M. B., and Fasipe, B. 2005. Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 288:289-293.
21. Murata, Y., Maeda, T., Miyamoto, E., and Kawashima, S. 1993. Preparation of chitosan-reinforced alginate gel beads - effects of chitosan on gel matrix erosion. Int. J. Pharm. 96:139-145.
22. Murata, Y., Miyamoto, E., and Kawashima, S. 1996. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads. J. Control. Rel. 38:101-108.
23. Norris, D. A., Puri, N., and Sinko, P. J. 1998. Effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev. 34:135-154.
24. Ohta, A., Taguchi, A., Takizawa, T., Adachi, T., Kimura, S., and Hashizume., N. 1997. The alginate reduce the postprandial glycaemic response by forming a gel with dietary calcium in the stomach of the rat. Int. J. Vitam. Nutr. Res. 67:55-61.
25. Polk, A., Amsden, B., Yao, K. D., Peng, T., and Goosen, M. F. A. 1994. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:178-185.
26. Prista, L. N., Alves, A. C., and Morgado, R. 1995.. Tecnologia Farmacêutica. Lisboa: Fundação Calouste Gulbenkian
27. Quong, D., and Neufeld, R. J. 1998. DNA protection from extracapsular nuclease, within chitosan-or poly-l-lysine -coated alginate beads. Biotechnol. Bioeng. 60:124-134.
28. Quong, D., Neufeld, R. J., Skjak-Braek, G., and Poncelet, D. 1998. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol. Bioeng. 57:438-446.
29. Reis, C. P., Neufeld, R. J., Ribeiro, A. J., and Veiga, F. 2006a. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomed. Nanotechnol., Biol. Med. 2:53-65.
30. Reis, C. P., Neufeld, R. J., Ribeiro, A. J., and Veiga, F. 2006b. Design of insulin-loaded alginate nanoparticles: influence of calcium ion on polymer gel matrix properties. Chem. Ind. Chem. Eng. Quart. 12:47-52.
31. Reis, C. P., Ribeiro, A. J., Houng, S., Veiga, F., and Neufeld, R. J. 2007. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity. Eur. J. Pharm. Sci. 30:392-397.
32. Reis, C. P., Ribeiro, A. J., Neufeld, R. J., and Veiga, F. 2006c. Alginate microparticles as novel carrier for oral insulin delivery. Biotechnol. Bioeng. 96:977-989.
33. Saez, A., Guzman, M., Molpeceres, J., and Aberturas, M. R. 2000. Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm. 50:379-387.
34. Sajeesh, S., and Sharma, C. P. 2006. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 325:147-154.
35. Sankalia, M., Mashru, R., Sankalia, J., and Sutariya, V. 2006. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Eur. J. Pharm. Biopharm. 65:215-32.
36. Schechter, Y., Mironchik, M., Rubinraut, S., Saul, A., Tsubery, H., and Fridkin, M. 2005. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin. Bioconjug. Chem. 16:913-920.
37. Sezer, A. D., and Akbuga, J. 1999. Release characteristics of chitosan treated alginate beads: Ii. Sustained release of a low molecular drug from chitosan treated alginate beads. J. Microencapsul. 16:687-696.
38. Shen, W. H., and Xu, R. J. 2000. Gastrointestinal stability and absorption of insulin in suckling pigs. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 125:389-401.
39. Silva, C. M., Ribeiro, A. J., Ferreira, D., and Veiga, F. 2006. Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation. Eur. J. Pharm. Sci. 29:148-159.
40. Smitha, B., Sridhar, S., and Khan, A. A. 2005. Chitosan-sodium alginate polyion complexes as fuel cell membranes. Eur. Polym. J. 41:1859-1866.
41. Takahashi, T., Takayama, K., Machida, Y., and Nagai, T. 1990. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int. J. Pharm. 61:35-41.
42. Tapia, C., Escobar, Z., Costa, E., Sapag-Hagar, J., Valenzuela, F., Busualto, C., Gai, M. N., and Yazdani-Pedram, M. 2004. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems. Eur. J. Pharm. Biopharm. 57:65-75.
43. Tiyaboonchai, W., Woiszwillo, J., Sims, R. C., and Middaugh, C. R. 2003. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int. J. Pharm. 255:139-151.
44. Zohuriaan, M. J., and Shokrolahi, F. 2004. Thermal studies on natural and modified gums. Polym. Test. 23:575-579.